Applied Dna Sciences (NASDAQ:BNBX) Posts Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) posted its quarterly earnings data on Friday. The company reported ($0.68) earnings per share for the quarter, Zacks reports.

Applied Dna Sciences Stock Down 6.4%

Shares of NASDAQ BNBX traded down $0.03 during mid-day trading on Friday, reaching $0.44. The company’s stock had a trading volume of 51,726 shares, compared to its average volume of 1,940,461. The company has a market cap of $2.49 million, a price-to-earnings ratio of 0.00 and a beta of 0.58. The firm’s fifty day simple moving average is $0.62. Applied Dna Sciences has a 52 week low of $0.44 and a 52 week high of $12.09.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.